Latest updates

15 September

2017

Bulletins

New threats provisions in the UK

The United Kingdom is one of the few jurisdictions to have provisions within the trade mark law relating to the making of unjustified threats. The aim of these provisions is to encourage trade mark proprietors to write to, and engage with, the primary infringer (generally the party attaching the infringing mark to the goods or

13 September

2017

Bulletins

European Commission’s position paper on IP Rights post Brexit

The European Commission’s Task Force for Brexit negotiations published its position paper on intellectual property rights (including geographical indications) on 6 September 2017. At present, the UK Government has not issued a reciprocal paper and until a formal Withdrawal agreement is concluded between the European Commission and the UK government, the post‑Brexit application of unitary

6 September

2017

Bulletins

Plausibility – EPO confirms requirements for using post-filed data to support a technical effect

The EPO’s Board of Appeal recently revoked a patent covering Bristol-Myers Squibb’s blockbuster oncology drug dasatinib (marketed as Sprycel®). This decision (T488/16) provides valuable guidance into avoiding the pitfalls, and exploiting third party vulnerabilities, associated with the issue of plausibility. Plausibility is central to a number of statutory requirements to patentability at the EPO including

28 July

2017

Bulletins

A tale of two flag poles – unauthorised use of Amazon product codes deemed infringement and passing off

The claimants in the case were Jadebay Limited and Noa and Nani Limited trading as The Discount Outlet. The defendant was Clarke-Coles Limited trading as Feel Good UK. Jadebay is the proprietor of the UK trade mark registration for the Design Elements trade mark (figure 1 below) protected in Class 20 for ‘Flagpoles Plastic Storage

12 July

2017

Bulletins

Supreme Court concludes Actavis’ pemetrexed products directly infringe Eli Lilly’s patent

The UK Supreme Court (SC) has today handed down its judgment in the on-going dispute between Eli Lilly and Actavis relating to anti-cancer drugs including pemetrexed. It was announced last week that the SC had found in favour of Eli Lilly, by concluding that Actavis’ products directly and indirectly infringe Lilly’s patent in the UK,

1 2 3 48

Events

November 2017

Attendees: Nina White, Joanna Peak, Jennifer O’Farrell

UCL IBIL Debate ‘Equivalents: K = Na. Is the genie out of the bottle?’, London, November 2017

November 2017

Attendee: Matthew Spencer

CIPA Life Sciences Conference, Speaker, Northampton, November 2017

November 2017

Attendee: Peter Vaughan

MarkMonitor 7th annual domain seminar, London, November 2017

November 2017

Attendee: Emma Pitcher

INTA Annual Leadership Meeting, Washington, November 2017

October 2017

Attendees: Adrian Hayes, Joanna Peak

AIPLA Annual Meeting, Washington, October 2017

October 2017

Attendee: Claire Baldock

AIPPI World Congress 2017, Sydney, Australia, October 2017

October 2017

Attendee: Jennifer O’Farrell

BIA UK Bioscience Forum, Speaker, London, October 2017

Hover to read more

Jennifer will be co-presenting on the session entitled ‘Developing and delivering Advanced Therapies – clinical trials are just the start’, which will discuss how to use patents to secure the value of your product, ways to streamline your supply chain and how to obtain market access and reimbursement.

October 2017

Attendee: Emma Pitcher

IPIC 91st Annual Meeting, Panellist, Ottawa, Canada, October 2017

Hover to read more

Emma will be on the panel discussing ‘Sounds, Scents, Flavours — An Update on Non-Traditional Marks in Canada, the US and the EU’.

October 2017

Attendee: Edward Ronan

London IP Summit, Attending, October 2017

September 2017

Attendees: Rohan Setna, Michelle Pratt, Simon Kahn

CIPA Congress 2017, London, September 2017

September 2017

Attendee: David Wortley

KTN Chemistry and Industrial Biotechnology Showcase, York September, 2017

September 2017

Attendees: Charlotte Duly, Daniela Paull

Marques 31st Annual Conference, Prague, Czech Republic, September 2017

September 2017

Attendee: Rohan Setna

MIP European Patent Reform Forum 2017, Paris, September 2017

August 2017

Attendee: Simon Binnie

Internet-of-Things-Thames-Valley, Reading, October 2017

boult.bites

boult.bites Biotech – Autumn 2017

The ten minute read that highlights topical issues for bio and life science sector participants

boult.bites TM – Summer 2017

In this edition of Boult. bites, we look back INTA 2017; we look at what constitutes ‘similar and/or complementary good and services’; we advise on maintaining trade mark rights in the EU, and finally highlight an often overlooked ground of revocation that trade mark owners should be aware of.

boult.bites Biotech – Spring 2017

The ten minute read that highlights topical issues for bio and life science sector participants.

Industry news

Guest posts from other sources. Clicking on the links will take you to an external site.

Search